Scarica l'app Stockscreener
46.13
2.72%
-1.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$47.42
Aprire:
$48.03
Volume 24 ore:
327.71K
Relative Volume:
0.60
Capitalizzazione di mercato:
$1.99B
Reddito:
-
Utile/perdita netta:
$-38.99M
Rapporto P/E:
-15.39
EPS:
-2.9966
Flusso di cassa netto:
$-24.94M
1 W Prestazione:
-6.18%
1M Prestazione:
-6.18%
6M Prestazione:
-11.07%
1 anno Prestazione:
-5.10%
Intervallo 1D:
$46.07
$48.49
Intervallo di 1 settimana:
$46.07
$50.93
Portata 52W:
$36.61
$60.92
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Nome
Soleno Therapeutics Inc
Settore
Industria
Telefono
650-213-8444
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Confronta SLNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
46.13 | 1.99B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-12-02 | Reiterato | Stifel | Buy |
| 2024-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-05 | Iniziato | Piper Sandler | Overweight |
| 2024-01-23 | Iniziato | Stifel | Buy |
| 2023-11-21 | Ripresa | Guggenheim | Buy |
| 2020-09-29 | Iniziato | Guggenheim | Buy |
| 2020-01-10 | Iniziato | Craig Hallum | Buy |
| 2019-12-23 | Iniziato | Oppenheimer | Outperform |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
Mostra tutto
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Evolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight - GlobeNewswire Inc.
Allspring Global Investments Holdings LLC Sells 13,396 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
TimesSquare Capital Management LLC Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lowered by Allspring Global Investments Holdings LLC - MarketBeat
(SLNO) Long Term Investment Analysis - Stock Traders Daily
Soleno Therapeutics (NASDAQ:SLNO) Stock Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Soleno Therapeutics (NASDAQ:SLNO) Stock Passes Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Price Target at $71.20 - Defense World
What is Lifesci Capital's Estimate for SLNO Q4 Earnings? - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Upgraded by Lifesci Capital to Strong-Buy Rating - MarketBeat
Trend Tracker for (SLNO) - Stock Traders Daily
Equities Analysts Set Expectations for SLNO Q4 Earnings - Defense World
SLNO Stock Sees Surge of Approximately 3.38% in Last Five Days - Knox Daily
What was Soleno Therapeutics Inc (SLNO)’s performance in the last session? - US Post News
Lifesci Capital Upgrades Soleno Therapeutics (NASDAQ:SLNO) to “Strong-Buy” - Defense World
BlackRock, Inc. Reduces Stake in Soleno Therapeutics Inc - GuruFocus.com
Moody Aldrich Partners LLC Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
Soleno Therapeutics to Participate in Upcoming February Investor Conferences - The Manila Times
Soleno Therapeutics, Inc. to Participate in February Investor Conferences - Nasdaq
Rare Disease Pioneer Soleno Takes Center Stage at Major Healthcare Investment Forums - StockTitan
(SLNO) Investment Report - Stock Traders Daily
Soleno Therapeutics executives receive pay raises and bonuses - MSN
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by JPMorgan Chase & Co. - Defense World
Soleno Therapeutics executives receive pay raises and bonuses By Investing.com - Investing.com Nigeria
Soleno Therapeutics Enhances Executive Compensation Structure - TipRanks
Brokers Set Expectations for SLNO FY2025 Earnings - Defense World
Equities Analysts Issue Forecasts for SLNO FY2025 Earnings - MarketBeat
High Growth Tech Stocks to Watch in January 2025 - Simply Wall St
Soleno Therapeutics Breaks Above 200-Day Moving AverageBullish for SLNO - Nasdaq
Soleno Therapeutics (NASDAQ:SLNO) Trading 8.6% HigherHere's What Happened - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $74.83 Consensus PT from Brokerages - MarketBeat
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages - Defense World
Is Soleno Therapeutics (SLNO) the Top Small Cap Stock to Buy with the Highest Upside Potential? - MSN
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey
Analysts Predict How High Soleno Therapeutics Inc (SLNO) Will Go. - Stocks Register
Have Insiders Sold Soleno Therapeutics Shares Recently? - Simply Wall St
Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights
Trading (SLNO) With Integrated Risk Controls - Stock Traders Daily
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance
Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Soleno Therapeutics Inc Azioni (SLNO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Yen Kristen | SEE REMARKS |
Jan 03 '25 |
Sale |
46.18 |
2,340 |
108,053 |
76,605 |
| Mackaness James H | CHIEF FINANCIAL OFFICER |
Jan 02 '25 |
Sale |
45.41 |
4,083 |
185,406 |
115,089 |
| Mackaness James H | CHIEF FINANCIAL OFFICER |
Jan 03 '25 |
Sale |
46.18 |
3,791 |
175,055 |
111,298 |
| Hirano Patricia C | SEE REMARKS |
Jan 02 '25 |
Sale |
45.41 |
1,571 |
71,338 |
107,361 |
| Hirano Patricia C | SEE REMARKS |
Jan 03 '25 |
Sale |
46.18 |
1,459 |
67,371 |
105,902 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER |
Jan 02 '25 |
Sale |
45.41 |
10,937 |
496,640 |
708,616 |
| Anish Bhatnagar | CHIEF EXECUTIVE OFFICER |
Jan 03 '25 |
Sale |
46.18 |
10,154 |
468,875 |
698,462 |
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):